Patents Assigned to Sulfilatec, Inc.
  • Patent number: 11376278
    Abstract: Embodiments of the invention provide pharmaceutical compositions and methods for preventing and treating disease and promoting the health in subjects at risk of cardiovascular disease and/or kidney disease. Additional embodiments of the present invention provide compositions and methods useful for treating and preventing a cardiovascular disease or a kidney disease.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: July 5, 2022
    Assignee: Sulfilatec, Inc.
    Inventors: Christopher Cummings, David Shifrin